Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chef Nominees Limited is a London-based nominee company that functions as a specialized investment vehicle for Charterhouse Capital Partners. The entity is primarily utilized to hold significant equity positions and manage voting interests in portfolio companies, particularly within the healthcare, life sciences, and medical technology sectors. Historically, Chef Nominees has been a major shareholder in organizations such as Cross Country Healthcare, Inc., where it influenced corporate governance and strategic direction in the healthcare staffing and clinical trials markets. It also held interests in medical device firms like MicroMed Cardiovascular, supporting the development of cardiovascular support systems. As a subsidiary of the Charterhouse group, it facilitates institutional investment and capital management for private equity funds focused on European and North American healthcare markets. The company typically operates in conjunction with Charterhouse Equity Partners to oversee large-scale investments in the healthcare services and pharmaceutical outsourcing industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chef Nominees.